Navigation Links
Houston-Based Tyrell, Inc. Completes $28 Million Private Equity Financing
Date:7/11/2008

HOUSTON, July 11 /PRNewswire/ -- Tyrell, Inc., the creators of Zeno, an innovative hand-held medical device used in the treatment of acne, today announced that the company has closed a $28 million round of equity financing. The investment was led by Sante Ventures and Catterton Partners, and joined by existing investor Austin Ventures. Tyrell will use the funds to support expanded distribution of the Zeno line as well as to support new product introductions.

Kevin Lalande, Managing Partner for Sante Ventures and Michael Farello, partner at Catterton Partners will join the company's Board of Directors.

"Tyrell has developed a plan to develop consumer products around their proprietary ClearPoint technology in various product categories," said Mr. Lalande. "They have achieved category leadership in Acne Care and are poised to repeat that success in other skin care segments. We at Sante Ventures have followed this company since inception and we are pleased to have the opportunity to become an investment partner."

"Tyrell has built both a brand and a product line which provides a platform for growth," said Mr. Farello. "By focusing on increasing retail velocity and new product introductions, Tyrell is poised to become a major player in the emerging Personal Medical Device category and in personal care more broadly."

Blaine Wesner, General Partner at Austin Ventures will continue as a member of the company's Board of Directors. He noted:

"We continue to be very impressed with the management team at Tyrell as well as the innovative technology being commercialized in the Zeno product line."

Walter Klemp, President and CEO of Tyrell, closed by saying, "The founders of Sante Ventures have broad healthcare investment experience and we are honored that they have chosen to lead this financing round. Catterton Partners brings a breadth of investment expertise in the consumer industry making them an ideal investment partner at our current stage. The addition of these two very experienced investment firms to our highly regarded original investment partners is testament to the progress achieved by the company and the unique investment opportunity Tyrell represents."

About Tyrell, Inc. and Zeno(R)

Established in Houston, Texas, in September 2002, Tyrell, Inc. is the leading pioneer in the category of personal medical devices. The company was formed to develop and launch Zeno, a product set to revolutionize over-the-counter treatment of acne pimples. Utilizing proprietary ClearPoint technology, Zeno electronic medical devices apply sustained heat therapy to destroy the bacteria that causes common acne, dramatically reducing the healing time of pimples. The Zeno acne product line includes Zeno MD, Zeno PRO, Zeno and Zeno Mini. For more information, visit http://www.myzeno.com.

About Sante Ventures

Sante Ventures is a specialized venture capital firm founded in 2006 by a group of partners with deep healthcare investment and operations experience. In addition to capital, the firm provides its portfolio executives with additional healthcare domain expertise, an extensive network of relationships and singular industry focus. Sante invests exclusively in early-stage companies developing innovative new medical technologies and healthcare services. For more information, please visit http://www.santeventures.com

About Catterton Partners

With more than $2.3 billion under management, Catterton Partners is a leading private equity firm in the U.S. focused exclusively on the consumer industry. Since its founding in 1990, Catterton has leveraged its investment capital, strategic and operating skills, and network of industry contacts to establish one of the strongest investment track records in the consumer industry. Catterton invests in all major consumer segments, including food and beverage, retail and restaurants, consumer products and services, and media and marketing services. Catterton has led investments in companies such as Wellness Pet Food, The Worth Collection, Build-A-Bear Workshop, P.F. Chang's China Bistro, Fekkai and Kettle Foods. More information about the firm can be found at http://www.cpequity.com.

About Austin Ventures

Austin Ventures, with $3 billion dollars under management across nine funds, has provided startup and growth capital to emerging companies for over twenty years. We partner with exceptionally talented entrepreneurs and operating executives to build valuable businesses in a variety of technology and service industries. We invest nationally but maintain a particular focus on Texas, where we are the region's most active investor. Our team of investment professionals works with companies at every stage of the funding lifecycle, from initial seed investments, through startup and growth capital, to management-led buyouts and recapitalizations. Austin Ventures brings a long-term investment perspective, broad experience in building high-growth companies, and access to an unparalleled network of entrepreneurs and executives. Visit http://www.austinventures.com for more information.


'/>"/>
SOURCE Tyrell, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Houston-Based LifeGift Becomes States Only Stand-Alone Organ and Tissue Recovery Agency
2. Tianyin Pharmaceutical Co., Inc. Completes Production for Earthquake
3. Two Little Hands Productions Completes the Second Series of Signing Time With Two New DVDs
4. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
5. USHIFU, LLC Completes Acquisition of Focus Surgery, Inc.
6. Southern Home Medical Equipment Completes 1-for-1,000 Reverse Split and Begins Trading Under New Symbol SHOM
7. KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission
8. Beeston completes drilling on Bluff Lake property, 100 Mile House
9. PreMD Successfully Completes Project for Health & Beauty Company
10. Sinexus Welcomes New CEO and Completes Series B
11. ACTS Retirement-Life Communities Completes Carlton Cove Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... (PRWEB) , ... February 06, 2016 , ... Shark ... to announce the launch of a new DRTV campaign with Belly Bands. , Having ... tried everything from sprays to puppy pads and find nothing works, get Belly ...
(Date:2/5/2016)... ... ... Love is in the air at King Kullen! The local grocer is ... staple for Valentine’s Day is a must-have, and can be picked up with all ... are long-stem roses available, but also other flower bouquets, elegantly wrapped and ready to ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... and setting the stage for new clinical and scientific initiatives have all marked ... after she was appointed President and CEO of the nation’s oldest cancer center, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco ... micro-needling services in their Napa Valley office. The technique utilizes the body’s own ... Dr. Canales and Dr. Furnas, are part of only a select few cosmetic ...
(Date:2/5/2016)... ... ... After years as an active staff surgeon and having served as the director ... transitioned to chief of the Division of Plastic Surgery at what is now known ... began a second three-year term in January of 2016. , The original selection was ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Bernstein Liebhard LLP today announced that a securities class ... for the District of Arizona on ... or entities who purchased common shares of Insys Therapeutics Inc. ... 3, 2015 through January 25, 2016 (the "Class Period").  The ... of the Securities Exchange Act of 1934.  ...
(Date:2/4/2016)... 4, 2016 Wegener Polyangiitis - Pipeline ... Direct,s, ,Wegener Polyangiitis - Pipeline Review, H2 2015, ... pipeline. This report provides comprehensive information on ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ...
(Date:2/4/2016)... 2016 Summary Breast cancer, a malignant ... most common cancer in women worldwide, accounting for 16% ... The number of women diagnosed with breast cancer has ... of deaths has declined due to earlier diagnosis and ... revolutionized in the past four decades, especially with increasing ...
Breaking Medicine Technology: